June 19th 2024
A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.
FDA approves first generic Actos to treat type 2 diabetes
August 17th 2012FDA approved Mylan Pharmaceutical's 15-mg, 30-mg, and 45-mg pioglitazone hydrochloride tablets, the first generic version of Actos (Takeda), along with diet and exercise to improve blood glucose control in adults with type 2 diabetes.
HHS partners with pharmacies to educate Medicare beneficiaries about new health benefits
August 16th 2012The U.S. Department of Health and Human Services has created partnerships with several pharmacies to help patients learn about new Medicare benefits available under the Affordable Care Act, the healthcare reform legislation that was upheld as constitutional by the Supreme Court in late June.
Medication reconciliation important to avoid errors
August 16th 2012It’s important to put processes in place to be sure a patient’s medication list at discharge from the hospital is the same information that is provided to the primary care physician to avoid medication errors, according to a recent study published online July 24 in The Annals of Pharmacotherapy.
FDA warns of possible fatalities from codeine use in some children after surgical procedures
August 15th 2012FDA has issued a Drug Safety Communication concerning three children who died and one child who experienced a nonfatal but life-threatening case of respiratory depression after taking the pain-reliever codeine following tonsillectomy and/or adenoidectomy.
Generics saved Americans $1 trillion over 10 years
August 14th 2012The use of generic prescription drugs instead of their brand-name counterparts has saved Americans and the nation’s healthcare system $1.07 trillion over 10 years ending in 2011, according to the results of a study commissioned by the Generic Pharmaceutical Association.
FDA grants accelerated approval for treatment of rare type of leukemia
August 10th 2012FDA has approved vincristine sulfate liposome injection for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) who have had at least two relapses or whose disease has progressed following two or more anti-leukemia therapies.
ACA means ups, downs for various stakeholders in the generics game
August 10th 2012That the Supreme Court upheld the Affordable Care Act bodes well for the generic drug market, which is already growing by leaps and bounds annually. Industry consultants expect ACA implementation to notably benefit retail pharmacists, PBMs, and drug wholesalers.